New technologies delivered to your inbox Subscribe
34509 – The University of Central Florida invention relates to a two-step, blood-based cancer screening test. The first step screens for elevated levels of Fibroblast Growth Factor 19 (FGF19) via a standard enzyme-linked immunosorbent assay (ELISA). Patients with elevated levels of FGF19 continue with a second/follow-up test using oral cholestyramine as a “suppression” drug to verify that... Read More
34329 – The University of Central Florida invention relates to methods for inhibiting the expression of the “stemness” genes, NANOG/P8 and OCT4 in Glioblastoma Multiforme cancer stem cells. Short hairpin RNAs (shRNAs) were specifically designed to inhibit the expression of NANOG/P8 or OCT4 and were delivered by lentiviral transduction. Exosomal delivery of the shRNAs is currently in... Read More
34364 – Tumor-targeting nanoparticles induce ferroptosis in cancer cells without need for external activation Researchers at the University of Central Florida have developed a tumor-targeting nanoparticle system for chemodynamic therapy (CDT). The conjugated polymer nanoparticles (CPNPs) deliver iron for CDT at the targeted tumor site. In contrast to photodynamic therapy, which requires external... Read More
33949 – New compounds that focus on depriving cells of key nutrients may be useful as anticancer and anti-infective agents. Researchers at UCF and the Torrey Pines Institute for Molecular Studies have identified new compounds to inhibit the growth of human cancers and parasitic infections through nutrient deprivation. The compounds inhibit the import of large neutral amino acids such as leucine... Read More
31194 – Methods, systems and compositions of a biocompatible nanoparticle wherein normal, non-transformed, healthy cells are protected from oxidative stress, radiation therapy and chemotherapy while cancer cells are provided no protection Current treatments for cancer such as radiation and chemotherapy utilize the effects of oxidative stress and other reactive oxygen species to kill off diseased... Read More
31005 – The composition and synthesis of a biodegradable polymer coated ceria oxide nanoparticle Cerium oxide (CeO) nanoparticles exhibit potent antioxidant properties, as well as other desirable therapeutic characteristics such as prolonging neuronal cell life and protecting cells against UV radiation. Current methods of ceria nanoparticle synthesis and coating are expensive and have little... Read More
30450 – A probe that simultaneously performs optical coherence tomography (OCT) and spectral analysis using back reflected light The present invention provides a tunable source of low-coherence light to simultaneously conduct spatial imaging and spectral sensing for tissue diagnosis. It offers a real time three dimensional colposcopy diagnosis and the detailed guidance to physically biopsy... Read More
32194 – This discovery provides methods and compounds for decreasing the expression of LIMK1 and AurKA in cancer cells. Metastasis of tumor cells contributes to about 90% of cancer-related deaths. Proteins that regulate cell motility are attractive targets for cancer therapy because they can also play key roles in cell survival, proliferation, and migration. Lim kinase 1 (LIMK1) is a protein that... Read More
33036 – By forming a polymer casing that can encapsulate nanoparticles to deliver them to specific locations in the human body based on the polymer spheres’ shape, researchers have developed a technology to advance biomedical treatment and diagnosis. This ability to produce polymeric particles with a size, shape, and composition that determines finely-tuned physiochemical properties is made more... Read More
33361 – UCF researchers have created a new weapon in the fight against cancer by coating nanoparticles of cerium oxide, nanoceria, with polymers to affect the localization of nanoceria within cells and modulate its toxicity based on pH, to fight cancer cells while protecting normal cells. Even in the presence of oxygen, many cancers preferentially obtain their energy by converting glucose into... Read More
30810 – Novel motuporamine analogues with high anti-metastatic activity and low toxicity. UCF researchers have synthesized novel motuporamine analogues that act as anti-metastatic agents with low toxicity and high anti-migration activities. Motuporamines are naturally occurring anti-cancer compounds isolated from the sea sponge Xestospongia exigua. They have unique anti-migration and... Read More